Abstrait
Les mastectomies prophylactiques bilatérales représentent le moyen le plus efficace pour diminuer le risque de cancer du sein et le risque de décès par cancer du sein dans le cadre des familles à risque élevé.
Preview
Unable to display preview. Download preview PDF.
References
Anderson BO (2001) Prophylactic surgery to reduce breast cancer risk: abrief literature review. Breast J 7: 321–330
Appleton S, Fry A, Rees G, Rush R, Cull A (2000) Psychosocial effects of living with an increased risk of breast cancer: an exploratory study using telephone focus groups. Psychooncol 9: 511–521
Babiera GV, Lowy AD, Davidson BS, Eva Singletary SE (1997) The role of contralateral prophylactic mastectomy in lobular carcinoma. Breast J 3: 2–6
Barton FE Jr, English JM, Kingsley WB, Fietz M ( 1991 ) Glandular excision in total glandular mastectomy and modified radical mastectomy: a comparison. Plast Reconstr Surg 88: 389–392
Borgen PI, Hill AD, Tran KN et al. (1998) Patient regrets after bilateral prophylactic mastectomy. Ann Surg Oncol 5: 603–606
Brinton LA, Persson I, Boice JD Jr et al. (2001) Breast cancer risk in relation to amount of tissue removed during breast reduction operations in Sweden. Cancer 91: 478–483
Carlson GW, Bostwick J 3rd, Styblo TM et al. (1997) Skin-sparing mastectomy. Oncologic and reconstructive considerations. Ann Surg 225: 570–575; discussion 575-8
Contant CM, Menke-Pluijmers MB, Seynaeve C et al. (2002) Clinical experience of prophylactic mastectomy followed by immediate breast reconstruction in women at hereditary risk of breast cancer (HB(O)C) or a proven BRCA1 and BRCA2 germ-line mutation. Eur J Surg Oncol 28: 627–632
Dao TN, Verheyden CN (2005) TRAM flaps: a reconstructive option after bilateral nipple-sparing total mastectomy. Plast Reconstr Surg 116: 986–992
Eisen A, Rebbeck TR, Wood WC, Weber BL (2000) Prophylactic surgery in women with a hereditary predisposition to breast and ovarian cancer. J Clin Oncol 18: 1980–1995
Eisinger F, Bressac B, Castaigne D et al. (2004) Identification and management of hereditary predisposition to cancer of the breast and the ovary (update 2004). Bull Cancer 91: 219–237
Elit L, Rosen B, Goel V et al. (2001) Prophylactic oophorectomy in Ontario. Fam Cancer 1: 143–148
Frost MH, Schaid DJ, Sellers TA et al. (2000) Long-term satisfaction and psychological and social function following bilateral prophylactic mastectomy. JAMA 284: 319–324
Gabriel SE, Woods JE, O’Fallon WM et al. (1997) Complications leading to surgery after breast implantation. N Engl J Med 336: 677–682
Grann VR, Panageas KS, Whang W et al. (1998) Decision analysis of prophylactic mastectomy and oophorectomy in BRCA1-positive or BRCA2-positive patients. J Clin Oncol 16: 979–985
Meijers-Heijboer H, van Geel B, van Putten W et al. (2001) Breast Cancer after Prophylactic Bilateral Mastectomy in Women with a BRCA1 or BRCA2 Mutation. N Engl J Med 345: 159–164
Hartmann LC, Schaid DJ, Woods JE etal. (1999) Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med 340: 77–84
Hartmann LC, Sellers TA, Schaid DJ et al. (2001) Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. J Natl Cancer Inst 93: 1633–1637
Hatcher MB, Fallowfield L, A’Hern R (2001) The psychosocial impact of bilateral prophylactic mastectomy: prospective study using questionnaires and semistructured interviews. BMJ 322: 76
Jacobsen WM, Meland NB, Woods JE (1994) Autologous breast reconstruction with use of transverse rectus abdominis musculocutaneous flap: Mayo clinic experience with 147 cases. Mayo Clin Proc 69: 635–640
Josephson U, Wickman M, Sandelin K (2000) Initial experiences of women from hereditary breast cancer families after bilateral prophylactic mastectomy: a retrospective study. Eur J Surg Oncol 26: 351–336
Kauff ND, Satagopan JM, Robson ME et al. (2002) Risk-reducing salpingooophorectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 346: 1609–1615
Kirova YM, Stoppa-Lyonnet D, Savignoni A et al. (2005) For the Institut Curie Breast Cancer Study Group. Risk of breast cancer recurrence and contralateral breast cancer in relation to BRCA1 and BRCA2 mutation status following breast-conserving surgery and radiotherapy. Eur J Cancer 41: 2304–2311
Lee JS, Grant CS, Donohue JH et al. (1995) Arguments against routine controlateral mastectomy or undirected biopsy for invasive lobular breast cancer. Surgery 118: 640–667
Lostumbo L, Carbine N, Wallace J, Ezzo J (2004) Prophylactic mastectomy for the prevention of breast cancer. Cochrane Database of Systematic Reviews Issue 4
McDonnell SK, Schaid DJ, Myers JL et al. (2001) Efficacy of contralateral prophylactic mastectomy in women with a personal and family history of breast cancer. J Clin Oncol 19: 3938–3943
Meiser B, Tiller K, Gleeson MA et al. (2000) Psychological impact of prophylactic oophorectomy in women at increased risk for ovarian cancer. Psychooncol 9: 496–503
Metcalfe KA, Esplen MJ, Goel V, Narod SA (2004) Psychosocial functioning in women who have undergone bilateral prophylactic mastectomy. Psychooncol 13: 14–25
Metcalfe KA, Goel V, Lickley L et al. (2002) Prophylactic bilateral mastectomy: patterns of practice. Cancer 15 95: 236–242
Metcalfe KA, Lynch HT, Ghadirian P et al. (2005) The risk of ovarian cancer after breast cancer in BRCA1 and BRCA2 carriers. Gynecol Oncol 96: 222–226
Metcalfe KA, Semple JL, Narod SA (2004) Satisfaction with breast reconstruction in women with bilateral prophylactic mastectomy: a descriptive study. Plast Reconstr Surg 114: 360–366
Metcalfe KA (2004) Prophylactic bilateral mastectomy for breast cancer prevention. J Womens Health (Larchmt) 13: 822–829
Metcalfe KA (2002) Prophylactic bilateral mastectomy for breast cancer prevention. N Engl J Med 346: 1616–1622
Montgomery LL, Tran KN, Heelan MC et al. (1999) Issues of regret in women with contralateral prophylactic mastectomies. Ann Surg Oncol 6: 546–552
Pennisi VR, Capozzi A (1989) Subcutaneous mastectomy data: a final statistical analysis of 1500 patients. Aesthetic Plast Surg Winter 13: 15–21
Peralta EA, Ellenhorn JD, Wagman LD et al. (2000) Contralateral prophylactic mastectomy improves the outcome of selected patients undergoing mastectomy for breast cancer. Am J Surg 180: 439–445
Rebbeck TR, Friebel T, Lynch HT et al. (2004) Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. J Clin Oncol 22: 1055–1062
Rebbeck TR, Levin AM, Eisen A et al. (1999) Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers. J Natl Cancer Inst 91: 1475–1479
Rebbeck TR, Lynch HT, Neuhausen SL et al. (2002) Prevention and Observation of Surgical End Points Study Group. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N Engl J Med 346: 1616–1622
Schrag D, Kuntz KM, Garber JE, Weeks JC (1997) Decision analysis—effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations. N Engl J Med 336: 1465–1471
Simmons RM, Assay M (1997) Prophylactic mastectomy. Breast J 3: 372–379
Simmons RM, Hollenbeck ST, Latrenta GS (2003) Areola-sparing mastectomy with immediate breast reconstruction. Ann Plast Surg 51: 547–551
Spear SL, Carter ME, Schwarz K (2005) Prophylactic mastectomy: indications, options, and reconstructive alternatives. Plast Reconstr Surg 115: 891–909 Review
Spear SL, Majidian A (1998) Immediate breast reconstruction in two stages using textured, integrated-valve tissue expanders and breast implants: a retrospective review of 171 consecutive breast reconstructions from 1989 to 1996. Plast Reconstr Surg 101: 53–63
Stefanek M, Hartmann L, Nelson W (2001) Risk-reduction mastectomy: clinical issues and research needs. J Natl Cancer Inst 93: 1297–1306
Stefanek ME, Helzlsouer KJ, Wilcox PM, Houn F (1995) Predictors of and satisfaction with bilateral prophylactic mastectomy. Prev Med 24: 412–419
Van Sprundel TC, Schmidt MK, Rookus MA et al. (2005) Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers. Bri J Cancer 93 287–292
Tiller K, Meiser B, Gould L et al. (2005) Knowledge of risk management strategies, and information and risk management preferences of women at increased risk for ovarian cancer. Psychooncol 14: 249–261
Van Geel AN, Contant CM, Wai RT et al. (2003) Mastectomy by inverted drip incision and immediate reconstruction: data from 510 cases. Ann Surg Oncol 10: 389–395
Van Geel AN (2003) Prophylactic mastectomy: the Rotterdam experience. Breast 12: 357–361
Van Roosmalen MS, Verhoef LC, Stalmeier PF et al. (2002) Decision analysis of prophylactic surgery or screening for BRCA1 mutation carriers: a more prominent role for oophorectomy. J Clin Oncol 20: 2092–2100
Wickman M, Sandelin K, Arver B (2003) Technical Aspects and Outcome after Prophylactic Mastectomy and Immediate Breast Reconstruction in 30 Consecutive High-Risk Patients. Plastic & Reconstructive Surgery 111: 1069–1077
Willemsen HW, Kaas R, Peterse JH, Rutgers EJ (1998) Breast carcinoma in residual breast tissue after prophylactic bilateral subcutaneous mastectomy. Eur J Surg Oncol 24: 331–332
Zion SM, Slezak JM, Sellers TA et al. (2003) Reoperations after prophylactic mastectomy with or without implant reconstruction. Cancer 98: 2152–2160
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer-Verlag France, Paris
About this paper
Cite this paper
Bonnier, P. et al. (2007). Prise en charge par le chirurgien d’une élévation du risque de cancer du sein. In: Cancer du sein. Springer, Paris. https://doi.org/10.1007/978-2-287-71478-8_9
Download citation
DOI: https://doi.org/10.1007/978-2-287-71478-8_9
Publisher Name: Springer, Paris
Print ISBN: 978-2-287-71477-1
Online ISBN: 978-2-287-71478-8